In-vitro analysis of anti-oxidant potential of vanadium metallicum 12c and validating through open label randomized control trial in Type ii Diabetes Mellitus - NI

ational Institute of Homoeopathy0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年5月27日

试验速览

暂无简介。

•Age groups 30-70 of both sex and of all Religion.
•FBS 125- 150 mg/dl.
•PPBS 200- 300 mg/dl.
•HbA1C 6.5- 8 %
•Out of above 3 any two.
•Patient willing to give written consent for participating in the study and complete follow-up during study.
•Patients who are able to read Bengali/English/Hindi

•Patients age below 30 and above 70.
•Patients having severe complications like hypoglycaemia, retinopathy, neuropathy, diabetic foot, malignancy, severe cardiac disorders,
•HbA1C above 8,
•FBS above 150 mg/dl,
•PPBS above 300mg/dl or any other comorbidities.
•Immunocompromised patient.
•Patient suffering from any severe psychiatric illness.
•Patients not willing to give written consent.
•Patients not willing to undergo any investigation, if needed.
•Pregnant and lactating mothers.

发起方

ational Institute of Homoeopathy